Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Hepatitis C patients have a higher risk factor for liver cancer and other associated liver conditions.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
A look at two recent cancer studies. One showing an increased hepatitis prevalence in cancer patients; the other looks at high fiber diets.
A study found that people who had the largest increase in whole grain lowered their liver cancer risk by nearly 40 percent.
Highlights some of the latest hepatitis C and liver disease research.
Find out if you are at risk for liver cancer even if your hepatitis C treatment was successful and you are virus-free.
Seventy percent of liver cancer patients had either a partial response or stable disease.
A third of patients taking neoadjuvant Opdivo had complete responses in an early analysis.
Cabometyx is the third liver cancer drug approved in the past six months.
Half of people with worse liver function responded well to immunotherapy.
Liver fat may be a driver of increased cancer risk associated with obesity.
A second immunotherapy option is now available for hepatocellular carcinoma.
A new study examines the clinical and economic impact of new direct-acting antivirals.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.